Dr. Jia Ruan, M.D., Ph.D.

Claim this profile

NYP/Weill Cornell Medical Center

Studies Lymphoma
Studies Cutaneous T-Cell Lymphoma
5 reported clinical trials
14 drugs studied

Area of expertise

1Lymphoma
Jia Ruan, M.D., Ph.D. has run 3 trials for Lymphoma. Some of their research focus areas include:
Stage IV
CD3 positive
CD2 positive
2Cutaneous T-Cell Lymphoma
Jia Ruan, M.D., Ph.D. has run 2 trials for Cutaneous T-Cell Lymphoma. Some of their research focus areas include:
Stage II
Stage III
Stage IV

Affiliated Hospitals

Image of trial facility.
NYP/Weill Cornell Medical Center
Image of trial facility.
Weill Cornell Medicine

Clinical Trials Jia Ruan, M.D., Ph.D. is currently running

Image of trial facility.

Lenalidomide + EPOCH Chemotherapy

for Adult T-Cell Leukemia-Lymphoma

This phase I trial studies the side effects and best dose of lenalidomide when given together with usual combination chemotherapy (etoposide, prednisone, vincristine sulfate \[Oncovin\], cyclophosphamide, and doxorubicin hydrochloride \[hydroxydaunorubicin hydrochloride\], or "EPOCH") in treating adult T-cell leukemia-lymphoma. Lenalidomide may help shrink or slow the growth of adult T-cell leukemia-lymphoma. Drugs used in chemotherapy, such as etoposide, vincristine, cyclophosphamide, and doxorubicin, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Anti-inflammatory drugs such as prednisone lower the body's immune response and are used with other drugs in the treatment of some types of cancer. Giving lenalidomide and the usual combination chemotherapy may work better in treating adult T-cell leukemia-lymphoma compared to the usual combination chemotherapy alone.
Recruiting1 award Phase 1
Image of trial facility.

Duvelisib/CC-486 + Chemotherapy

for Lymphoma

This phase II trial studies the effect of duvelisib or CC-486 and usual chemotherapy consisting of cyclophosphamide, doxorubicin, vincristine, etoposide, and prednisone in treating patients with peripheral T-cell lymphoma. Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, doxorubicin, vincristine, etoposide and prednisone, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial may help find out if this approach is better or worse than the usual approach for treating peripheral T-cell lymphoma.
Recruiting1 award Phase 227 criteria

More about Jia Ruan, M.D., Ph.D.

Clinical Trial Related3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Jia Ruan, M.D., Ph.D. has experience with
  • Lenalidomide
  • Prednisone
  • Duvelisib
  • Acalabrutinib
  • Rituximab
  • Cyclophosphamide; Doxorubicin Hydrochloride; Etoposide; Vincristine Sulfate

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jia Ruan, M.D., Ph.D. specialize in?
Jia Ruan, M.D., Ph.D. focuses on Lymphoma and Cutaneous T-Cell Lymphoma. In particular, much of their work with Lymphoma has involved Stage IV patients, or patients who are CD3 positive.
Is Jia Ruan, M.D., Ph.D. currently recruiting for clinical trials?
Yes, Jia Ruan, M.D., Ph.D. is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Jia Ruan, M.D., Ph.D. has studied deeply?
Yes, Jia Ruan, M.D., Ph.D. has studied treatments such as Lenalidomide, Prednisone, Duvelisib.
What is the best way to schedule an appointment with Jia Ruan, M.D., Ph.D.?
Apply for one of the trials that Jia Ruan, M.D., Ph.D. is conducting.
What is the office address of Jia Ruan, M.D., Ph.D.?
The office of Jia Ruan, M.D., Ph.D. is located at: NYP/Weill Cornell Medical Center, New York, New York 10065 United States. This is the address for their practice at the NYP/Weill Cornell Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.